Reverse genetics can be used to generate recombinant rotaviruses expressing foreign epitopes, which may aid in developing novel rotavirus vaccines.
Answers are grounded in this paper and cite their sources.
Supports reverse genetics for foreign epitope expression in rotavirus; hypothesis-generating for vaccines pending growth optimization.
Recombinant rotavirus (RV) with cDNA-derived chimeric VP4 was generated using recently developed reverse genetics for RV. The rescued virus, KU//rVP4(SA11)-II(DS-1), contains SA11 (simian RV strain, G3P[2])-based VP4, in which a cross-reactive neutralization epitope (amino acids 381 to 401) on VP5* is replaced by the corresponding sequence of a different P-type DS-1 (human RV strain, G2P[4]). Serological analyses with a panel of anti-VP4- and -VP7-neutralizing monoclonal antibodies revealed that the rescued virus carries a novel antigenic mosaic of cross-reactive neutralization epitopes on its VP4 surface. This is the first report of the generation of a recombinant RV with artificial amino acid substitutions.
No takes yet. Share an insight, caveat, or question.
Komoto et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: